UniProtKB/Swiss-Prot Q30201 : Variant p.Val53Met
Hereditary hemochromatosis protein
Gene: HFE
Feedback ?
Variant information
Variant position:
53
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Valine (V) to Methionine (M) at position 53 (V53M, p.Val53Met).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Polymorphism:
Genetic variations in HFE may influence the transferrin serum levels. Iron is essential for biochemical functions such as oxygen transport and oxidative phosphorylation. Excessive iron can cause iron-overload-related liver diseases, whereas iron deficiency can lead to anemia. Iron status can be assessed by measuring the levels of serum iron, serum transferrin, transferrin saturation with iron, and serum ferritin.
Additional information on the polymorphism described.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
53
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
348
The length of the canonical sequence.
Location on the sequence:
LFMGASEQDLGLSLFEALGY
V DDQLFVFYDHESRRVEPRTP
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LFMGASEQDLGLSLFEALGYV DDQLFVFYDHESRRVEPRTP
Chimpanzee LFMGASEQDLGLSLFEALGYV DDQLFVFYDHESRRVEPRTP
Mouse LFMGASEPDLGLPLFEARGYV DDQLFVSYNHESRRAEPRAP
Rat LFMGASKPDLGLPFFEALGYV DDQLFVSYNHESRRAEPRAP
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
23 – 348
Hereditary hemochromatosis protein
Topological domain
23 – 306
Extracellular
Region
23 – 114
Alpha-1
Alternative sequence
26 – 114
RSHSLHYLFMGASEQDLGLSLFEALGYVDDQLFVFYDHESRRVEPRTPWVSSRISSQMWLQLSQSLKGWDHMFTVDFWTIMENHNHSKE -> Q. In isoform 2 and isoform 4.
Alternative sequence
27 – 298
Missing. In isoform 11.
Alternative sequence
27 – 206
Missing. In isoform 6.
Beta strand
48 – 53
Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS MET-53; ASP-63; GLN-224 AND TYR-282;
Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.
de Villiers J.N.P.; Hillermann R.; Loubser L.; Kotze M.J.;
Hum. Mol. Genet. 8:1517-1522(1999)
Cited for: VARIANTS HFE1 ASP-63; HIS-127 AND MET-330; VARIANTS MET-53 AND MET-59;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.